Camp4 Therapeutics (CAMP) Equity Average (2023 - 2025)
Camp4 Therapeutics (CAMP) has disclosed Equity Average for 3 consecutive years, with $53.2 million as the latest value for Q4 2025.
- Quarterly Equity Average rose 211.0% to $53.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.2 million through Dec 2025, up 211.0% year-over-year, with the annual reading at $55.4 million for FY2025, 282.96% up from the prior year.
- Equity Average hit $53.2 million in Q4 2025 for Camp4 Therapeutics, up from $49.3 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $57.4 million in Q1 2025 to a low of -$153.0 million in Q3 2024.
- Historically, Equity Average has averaged -$42.6 million across 3 years, with a median of -$47.9 million in 2024.
- Biggest five-year swings in Equity Average: soared 59.27% in 2024 and later surged 211.0% in 2025.
- Year by year, Equity Average stood at -$117.6 million in 2023, then skyrocketed by 59.27% to -$47.9 million in 2024, then soared by 211.0% to $53.2 million in 2025.
- Business Quant data shows Equity Average for CAMP at $53.2 million in Q4 2025, $49.3 million in Q3 2025, and $45.8 million in Q2 2025.